1. Home
  2. CTKB vs EQV Comparison

CTKB vs EQV Comparison

Compare CTKB & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • EQV
  • Stock Information
  • Founded
  • CTKB 1990
  • EQV 2024
  • Country
  • CTKB United States
  • EQV United States
  • Employees
  • CTKB N/A
  • EQV N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EQV
  • Sector
  • CTKB Health Care
  • EQV
  • Exchange
  • CTKB Nasdaq
  • EQV Nasdaq
  • Market Cap
  • CTKB 526.7M
  • EQV 461.8M
  • IPO Year
  • CTKB 2021
  • EQV 2024
  • Fundamental
  • Price
  • CTKB $3.92
  • EQV $10.38
  • Analyst Decision
  • CTKB Hold
  • EQV
  • Analyst Count
  • CTKB 4
  • EQV 0
  • Target Price
  • CTKB $6.00
  • EQV N/A
  • AVG Volume (30 Days)
  • CTKB 932.3K
  • EQV 32.5K
  • Earning Date
  • CTKB 11-04-2025
  • EQV 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • EQV N/A
  • EPS Growth
  • CTKB N/A
  • EQV N/A
  • EPS
  • CTKB N/A
  • EQV N/A
  • Revenue
  • CTKB $196,035,000.00
  • EQV N/A
  • Revenue This Year
  • CTKB $0.09
  • EQV N/A
  • Revenue Next Year
  • CTKB $7.45
  • EQV N/A
  • P/E Ratio
  • CTKB N/A
  • EQV $50.61
  • Revenue Growth
  • CTKB N/A
  • EQV N/A
  • 52 Week Low
  • CTKB $2.37
  • EQV $9.88
  • 52 Week High
  • CTKB $7.63
  • EQV $10.74
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 49.11
  • EQV 48.48
  • Support Level
  • CTKB $3.80
  • EQV $10.37
  • Resistance Level
  • CTKB $4.14
  • EQV $10.42
  • Average True Range (ATR)
  • CTKB 0.21
  • EQV 0.03
  • MACD
  • CTKB -0.03
  • EQV 0.00
  • Stochastic Oscillator
  • CTKB 41.24
  • EQV 55.56

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About EQV EQV Ventures Acquisition Corp.

EQV Ventures Acquisition Corp is a blank check company.

Share on Social Networks: